# Reassessment of the Risk of Hemolytic Syndrome in Patients With Chronic Lymphocytic Leukemia Treated With a Regimen Containing Venetoclax

> **NCT07691047** · NA · NOT_YET_RECRUITING · sponsor: **Private Hospital of Confluent, France** · enrollment: 130 (estimated)

## Conditions studied

- Chronic Lymphoid Leukemia

## Interventions

- **PROCEDURE:** Cervical, Thoracic, Abdominal, and Pelvic CT Scan

## Key facts

- **NCT ID:** NCT07691047
- **Lead sponsor:** Private Hospital of Confluent, France
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-31
- **Primary completion:** 2029-07-31
- **Final completion:** 2029-09-30
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2026-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07691047

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07691047, "Reassessment of the Risk of Hemolytic Syndrome in Patients With Chronic Lymphocytic Leukemia Treated With a Regimen Containing Venetoclax". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07691047. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*